KLRK1 and melanoma: To validate this observation in a human context, we tested in this cohort the cytotoxic properties of purified NK cells from patients before chemotherapy, against a human melanoma cell line ex vivo pretreated with DTIC at a dosage that triggers expression of NKG2D ligand [10].